all report title image

CHRONIC KIDNEY DISEASE DRUGS MARKET ANALYSIS

Chronic Kidney Disease Drugs Market, By Drug Class (ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), B-Blockers, Calcium Channel Blockers, Loop Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Others), By Route of Administration (Oral and Parentral), By Indication (Diabetic Nephropathy, Glomerulonephritis, Hypertensive Nephropathy, Polycystic Kidney Disease, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Aug 2024
  • Code : CMI1713
  • Pages :206
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Chronic Kidney Disease Drugs Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • AstraZeneca
  • Amgen Inc.
  • Hoffmann-La Roche Ltd.
  • Pfizer, Inc.
  • Sanofi
  • GlaxoSmithKline plc (GSK)
  • AbbVie Inc.
  • Keryx Biopharmaceuticals, Inc.
  • Kissei Pharmaceutical Co., Ltd.
  • Regeneron Pharmaceuticals, Inc.
  • Bayer AG
  • Reata Pharmaceuticals, Inc.
  • Ardelyx, Inc.
  • Boehringer Ingelheim International GmbH
  • Novo Nordisk A/S
  • Novartis AG
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Limited
  • Akebia Therapeutics, Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.